Kabimustine 100mg Injection

About

Kabimustine 100mg Injection, containing Carmustine, is a highly effective alkylating agent belonging to the nitrosourea class, widely utilized in the treatment of various cancers. Its primary mechanism of action involves the formation of DNA and RNA cross-links, which profoundly inhibits nucleic acid synthesis and repair, ultimately leading to cell cycle arrest and apoptosis in rapidly dividing cancer cells. A distinctive feature of carmustine is its high lipophilicity, enabling it to readily cross the blood-brain barrier, making it particularly valuable for treating primary and metastatic brain tumors. Administered intravenously, this potent cytotoxic agent requires careful monitoring due to its significant myelosuppressive and potential pulmonary toxicities. Its role in combination chemotherapy regimens for conditions like Hodgkin's lymphoma, non-Hodgkin's lymphoma, and multiple myeloma underscores its importance in oncology.

Uses

• Brain tumors (glioblastoma, medulloblastoma)
• Multiple myeloma
• Hodgkin's lymphoma
• Non-Hodgkin's lymphoma

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency are determined by the physician based on the patient's condition.

Benefits

• Effective against various cancers
• Crosses the blood-brain barrier
• Potent cytotoxic action
• Used in combination therapies
• Established efficacy in lymphomas
• Valuable for refractory cases

Side Effects

• Bone marrow suppression (delayed)
• Nausea
• Vomiting
• Stomatitis
• Diarrhea
• Pulmonary fibrosis (delayed)
• Hepatotoxicity
• Nephrotoxicity
• Alopecia
• Skin hyperpigmentation
• Injection site reactions
• Neurotoxicity (rare)

Safety Measures

• Alcohol - Avoid alcohol due to potential for increased gastrointestinal irritation and liver strain.
• Pregnancy - Contraindicated in pregnancy due to severe teratogenic and embryotoxic potential. Use effective contraception.
• Breastfeeding - Contraindicated during breastfeeding due to potential for serious adverse effects in the infant.
• Liver - Use with extreme caution in patients with hepatic impairment; monitor liver function closely. Dose adjustments may be necessary.
• Kidney - Use with caution in patients with renal impairment; monitor kidney function closely. Dose adjustments may be necessary.
• Lung - Significant risk of delayed pulmonary toxicity (fibrosis); monitor lung function, especially with cumulative doses.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.